Prediction of EVT6-NTRK3-Dependent Papillary Thyroid Cancer Using Minor Expression Profile

[1]  M. Sasiadek,et al.  Current Achievements and Applications of Transcriptomics in Personalized Cancer Medicine , 2021, International journal of molecular sciences.

[2]  Gajendra P.S. Raghava,et al.  Prognostic biomarkers for predicting papillary thyroid carcinoma patients at high risk using nine genes of apoptotic pathway , 2020, PloS one.

[3]  M. Ladanyi,et al.  Identifying patients with NTRK fusion cancer , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  K. Bencardino,et al.  Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  I. Berindan‐Neagoe,et al.  Gene Expression Patterns Unveil New Insights in Papillary Thyroid Cancer , 2019, Medicina.

[6]  A. Zehir,et al.  Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy , 2019, The Journal of molecular diagnostics : JMD.

[7]  Alexander E. Kel,et al.  Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer , 2019, BMC Bioinformatics.

[8]  A. Drilon,et al.  NTRK fusion-positive cancers and TRK inhibitor therapy , 2018, Nature Reviews Clinical Oncology.

[9]  J. Swensen,et al.  Molecular characterization of cancers with NTRK gene fusions , 2018, Modern Pathology.

[10]  Xiaoyun Liu,et al.  The diagnostic value of TROP-2, SLP-2 and CD56 expression in papillary thyroid carcinoma , 2018, European Archives of Oto-Rhino-Laryngology.

[11]  Chao Wang,et al.  Identification of novel long non-coding RNA biomarkers for prognosis prediction of papillary thyroid cancer , 2017, Oncotarget.

[12]  T. Giordano,et al.  Implications of the TCGA genomic characterization of papillary thyroid carcinoma for thyroid pathology: does follicular variant papillary thyroid carcinoma exist? , 2015, Thyroid : official journal of the American Thyroid Association.

[13]  M. Barbacid,et al.  Oncogenes in solid human tumours , 1982, Nature.

[14]  J. Cerutti,et al.  ETV6-NTRK3 and STRN-ALK kinase fusions are recurrent events in papillary thyroid cancer of adult population. , 2018, European journal of endocrinology.